Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss. Improving distant control of lung cancer is the most exciting potential benefit of combining ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

Alvotech and Dr. Reddy’s have entered into a collaboration and license agreement to co-develop, manufacture and commercialize ...

Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments ...

The approval introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head and neck squamous cell carcinoma.

Pembrolizumab significantly reduced the risk of event free survival events by 30% compared with standard of care.

The stars aligned on Friday and Saturday for the Aronui Drone Show above Kouramāwhitiwhiti (Rotorua Lakefront) for ...

FDA approvals and long-term study results, showcasing advancements in cancer treatments, and patient care strategies.

Merck’s first quarter results drew a positive market reaction, reflecting operational resilience despite a 1.6% ...

Merck & Co – known as MSD outside the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has ...

Haris Zeb’s challenge on Gianluca Prestianni offered Di María a chance to break the deadlock, and he didn’t blink, stroking a composed effort down the middle as Garrow committed to his right. City ...

With a backdrop of mounting industry disruption and transition, Pharm Exec’s latest listing of the top global biopharma sales ...